Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Using broad-spectrum antibiotics to prevent infections in orthopedic surgery

Official title: Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Sur-gery - the Prospective-randomized, Microbiologist-blinded, Stratified, Superiority Trials - BAPTIST Trials

Run by Balgrist University Hospital · NCT05502380 · Data updated 2026-11-12

This study tests whether using a stronger type of antibiotics before orthopedic surgery can help prevent infections in patients who are at high risk.

More Surgical Site Infection trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1100 (estimated)
SponsorBalgrist University Hospital
Academic / other
Locations1 site (Zurich)
StatusRecruiting
StartedSeptember 15, 2022
Main results expectedDecember 12, 2024
Study endsDecember 12, 2025
Registry record updatedDecember 2, 2024
Trial IDNCT05502380 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older undergoing high-risk orthopedic surgeries, particularly those with open fractures, tumors, or known skin colonization with multidrug-resistant bacteria.

Probably not a fit

Patients who are not undergoing surgery with a high risk of infection or those with allergies to the antibiotics used in the study may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of broad-spectrum antibiotic prophylaxis in preventing surgical site infections (SSIs) in high-risk orthopedic surgery patients. It focuses on patients undergoing procedures with a high likelihood of antibiotic-resistant infections, such as those with open fractures or tumors. The study will compare standard antibiotic prophylaxis with a more comprehensive approach to address the risk of newly introduced pathogens during surgery. Participants will be monitored for infection rates and microbial colonization post-surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of antibiotic-resistant surgical site infections in orthopedic patients.

How similar studies have gone: Previous studies have shown that tailored antibiotic prophylaxis can reduce infection rates, suggesting potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Age ≥ 18 years
* Surgery under current or recent therapeutic antibiotics (antibiotic-free window \<14 days and past antibiotic prescription \>4 days)
* Surgery for open fractures and wounds; including 2nd and 3rd looks
* Potentially contaminated wound revision in the operating theatre
* Tumor (oncologic) surgery (if prior radiotherapy and/or bone involvement)
* Spine surgery with ASA-Score \>= 3 points, sacral involvement, or re-vision surgery
* Known skin colonization with multidrug-resistant Gram-negative bacteria

Exclusion Criteria:

* Inability to understand the study procedure for linguistic or cognitive rea-sons
* Surgery without intraoperative microbiological samples
* Allergy or major intolerance to vancomycin and/or gentamicin
* Anticipated clinical follow-up of less than 6 weeks after inclusion
* Pregnant or breastfeeding women
* Known carriage of multiresistant Gram-negative bacteria in the urine or anal region

Where it's running

  • Balgrist University Hospital
    Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.